Finally, irAEs could not be predicted by baseline PD-L1 uptake; however, an increase in thyroid PD-L1 PET uptake on-treatment only occurred in patients with thyroid toxicity or a history of thyroid disease. This evidence concerns the gene CD274 and thyroiditis.